title: Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Schifano
authors.forename: Stefano
authors.initials: S
authors.lastname: D'Offizi
authors.forename: Michele
authors.initials: M
authors.lastname: Piccione
authors.forename: Ornella
authors.initials: O
authors.lastname: Corazza
authors.forename: Paolo
authors.initials: P
authors.lastname: Deluca
authors.forename: Zoe
authors.initials: Z
authors.lastname: Davey
authors.forename: Giuditta
authors.initials: G
authors.lastname: Di Melchiorre
authors.forename: Lucia
authors.initials: L
authors.lastname: Di Furia
authors.forename: Magí
authors.initials: M
authors.lastname: Farré
authors.forename: Liv
authors.initials: L
authors.lastname: Flesland
authors.forename: Miia
authors.initials: M
authors.lastname: Mannonen
authors.forename: Aino
authors.initials: A
authors.lastname: Majava
authors.forename: Stefania
authors.initials: S
authors.lastname: Pagani
authors.forename: Teuvo
authors.initials: T
authors.lastname: Peltoniemi
authors.forename: Holger
authors.initials: H
authors.lastname: Siemann
authors.forename: Arvid
authors.initials: A
authors.lastname: Skutle
authors.forename: Marta
authors.initials: M
authors.lastname: Torrens
authors.forename: Cinzia
authors.initials: C
authors.lastname: Pezzolesi
authors.forename: Peer
authors.initials: P
authors.lastname: van der Kreeft
authors.forename: Norbert
authors.initials: N
authors.lastname: Scherbaum
mesh_terms: D000588:Amines / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D002998:Clonazepam / Q000009:adverse effects; D003430:Cross-Sectional Studies; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D004347:Drug Interactions; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D005060:Europe; D000077206:Gabapentin; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects; D000069583:Pregabalin; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000523:psychology; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D013287:Illicit Drugs; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D002998:Clonazepam; D000077206:Gabapentin